Modulation of the intestinal microbiota and the metabolites produced by the administration of ice cream and a dietary supplement containing the same probiotics

British Journal of Nutrition

Volumn 124, Issue 1, 2020, Pages 57-68

  Da Cruz Rodrigues, Vivian Cristina ^a   Rocha Faria Duque, Ana Luiza ^b   De Carvalho Fino, Luciana ^a   Simabuco, Fernando Moreira ^a   Sartoratto, Adilson ^a   Cabral, Luc lia ^c   Noronha, Melline Fontes ^d   Sivieri, Katia ^b   Antunes, Adriane Elisabete Costa ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c BRAZILIAN CENTER FOR RESEARCH IN ENERGY AND MATERIALS CNPEM   (Brazil)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Ammonia; Bifidobacterium animalis; Fatty acids; Lactobacillus acidophilus; SHIME

Indexed keywords

ACETIC ACID; AMMONIA; BUTYRIC ACID; INULIN; PROBIOTIC AGENT; PROPIONIC ACID;

ADULT; ARTICLE; BACTEROIDES; BIFIDOBACTERIUM ANIMALIS; CONTROLLED STUDY; DIETARY SUPPLEMENT; FAECALIBACTERIUM; HUMAN; HUMAN EXPERIMENT; ICE CREAM; INTESTINE FLORA; LACTOBACILLUS ACIDOPHILUS; METABOLITE; MICROBIAL DIVERSITY; NONHUMAN; NORMAL HUMAN; YOUNG ADULT;

EID: 85081932656     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114520000896     Document Type: Article

References (117)

1. Cani PD (2018) Human gut microbiome: hopes, threats and promises. Gut 67, 1716-1725.
2. Rinninella E, Raoul P, Cintoni M, et al. (2019) What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms 7, E14.
3. Natividad JMM & Verdu EF (2013) Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications. Pharmacol Res 69, 42-51.
4. Khosravi A & Mazmanian SK (2013) Disruption of the gut microbiome as a risk factor for microbial infections. Curr Opin Microbiol 16, 221-227.
5. Doré J, Simrén M, Buttle L, et al. (2013) Hot topics in gut microbiota. United European Gastroenterol J 1, 311-318.
6. Bäumler AJ & Sperandio V (2016) Interactions between the microbiota and pathogenic bacteria in the gut. Nature 535, 85-93.
7. Den Besten G, Van Eunen K, Groen AK, et al. (2013) The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 54, 2325-2340.
8. Gensollen T, Iyer SS, Kasper DL, et al. (2016) How colonization by microbiota in early life shapes the immune system. Science 352, 539-544.
9. Schmidt TSB, Raes J & Bork P (2018) The human gut microbiome: from association to modulation. Cell 172, 1198-1215.
10. Gibson GR & Roberfroid MB (1995) Dietary modulation of the human colonic microflora: introducing the concept of prebiotics. J Nutr 125, 1401-1412.
11. Bron PA, Van Baarlen P & Kleerebezem M (2012) Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat Rev Microbiol 10, 66-78.
12. Hemaiswarya S, Raja R, Ravikumar R, et al. (2013) Mechanism of action of probiotics. Braz Arch Biol Technol 56, 113-119.
13. O'Flaherty S, Saulnier DM, Pot B, et al. (2010) How can probiotics and prebiotics impact mucosal immunity? Gut Microbes 1, 293-300.
14. Gerritsen J, Smidt H, Rijkers GT, et al. (2011) Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr 6, 209-240.
15. Ranadheera RDCS, Baines SK & Adams MC (2010) Importance of food in probiotic efficacy. Food Res Int 43, 1-7.
16. Sanders ME & Marco ML (2010) Food formats for effective delivery of probiotics. Annu Rev Food Sci Technol 1, 65-85.
17. Saad N, Delattre C, Urdaci M, et al. (2013) An overview of the last advances in probiotic and prebiotic field. LWT Food Sci Technol 50, 1-16.
18. Kotarski SF & Savage DC (1979) Models for study of the specificity by which indigenous lactobacilli adhere to murine gastric epithelia. Infect Immun 26, 966-975.
19. Guarner F & Malagelada JR (2003) Gut flora in health and disease. Lancet 361, 512-519.
20. Nader-Macías MEF & Tomás MSJ (2015) Profiles and technological requirements of urogenital probiotics. Adv Drug Deliv Rev 92, 84-104.
21. Cruz AG, Antunes AEC, Sousa ALOP, et al. (2009) Ice-cream as a probiotic food carrier. Food Res Int 42, 1233-1239.
22. Hill C, Guarner F, Reid G, et al. (2014) The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11, 506-514.
23. Ministério da Saúde, Brazil (Health Ministry, Brazil) (2003) Resolução RDC n. 359, de 23 de dezembro de 2003 (Resolution RDC no. 359, 23 December 2003). Aprova Regulamento Técnico de Porções de Alimentos Embalados para Fins de Rotulagem Nutricional (Approves technical regulation of portions of packaged foods for nutrition labeling). http:// portal.anvisa.gov.br/documents/33880/2568070/res0359-23-12-2003.pdf/76676765-a107-40d9-bb34-5f05ae897bf3 (accessed January 2019).
24. Ministério da Saúde, Brazil (Health Ministry, Brazil) (2018) Resolução RDC n. 243, de 26 de julho de 2018 (Resolution RDC no. 243, 26 July 2018). Dispõe sobre os requisitos sanitários dos suplementos alimentares (Provides for the health requirements of food supplements). http://www.in.gov.br/ materia/-/asset-publisher/Kujrw0TZC2Mb/content/id/34379969/ do1-2018-07-27-resolucao-da-diretoria-colegiada-rdc-n-243-de-26-de-julho-de-2018-34379917 (accessed January 2019).
25. Van de Wiele T, Boon N, Possemiers S, et al. (2004) Prebiotic effects of chicory inulin in the simulator of the human intestinal microbial ecosystem. FEMS Microbiol Ecol 51, 143-153.
26. Marzorati M, Qin B, Hildebrand F, et al. (2015) Addition of acacia gum to a FOS/inulin blend improves its fermentation profile in the Simulator of the Human Intestinal Microbial Ecosystem (SHIME®). J Funct Foods 16, 211-222.
27. Verhoeckx K, Cotter P, López-Expósito I, et al. (2015) In vitro fermentation models: general introduction. In The Impact of Food Bio-Actives on Gut Health: In Vitro and Ex Vivo Model, pp. 275-279 [K Verhoeckx, P Cotter, I López-Exṕosito, et al., editors]. London: Springer.
28. Aura A-M & Maukonen J (2015) One compartment fermentation model. In The Impact of Food Bio-Actives on Gut Health: In Vitro and Ex Vivo Models, pp. 281-292 [K Verhoeckx, P Cotter, I López-Expósito, et al., editors]. London: Springer.
29. Venema K (2015) The TNO In Vitro Model of the colon (TIM-2). In The Impact of Food Bio-Actives on Gut Health: In Vitro and Ex Vivo Model, pp. 293-304 [K Verhoeckx, P Cotter, I López-Exṕosito, et al., editors]. London: Springer.
30. Van de Wiele T, Van den Abbeele P, Ossieur W, et al. (2015) The Simulator of the Human Intestinal Microbial Ecosystem (SHIME®). In The Impact of Food Bio-Actives on Gut Health: In Vitro and Ex Vivo Model, pp. 305-317 [K Verhoeckx, P Cotter, I López-Exṕosito, et al., editors]. London: Springer.
31. Barroso E, Cueva C, Peláez C, et al. (2015) The computercontrolled multicompartmental dynamic model of the gastrointestinal system SIMGI. In The Impact of Food Bio-Actives on Gut Health: In Vitro and Ex Vivo Model, pp. 319-327 [K Verhoeckx, P Cotter, I López-Exṕosito, et al., editors]. London: Springer.
32. Possemiers S, Marzorati M, Verstraete W, et al. (2010) Bacteria and chocolate: a successful combination for probiotic delivery. Int J Food Microbiol 141, 97-103.
33. Rodrigues VCC, Silva LGS, Simabuco FM, et al. (2019) Survival, metabolic status and cellular morphology of probiotics in dairy products and dietary supplement after simulated digestion. J Funct Foods 55, 126-134.
34. Magariños H, Selaive S, Costa M, et al. (2007) Viability of probiotic micro-organisms (Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis Bb-12) in ice cream. Int J Dairy Technol 60, 128-134.
35. Instituto Adolfo Lutz (IAL) (2008) Métodos físico-químicos para análise de alimentos (Physico-chemical Methods for Food Analysis), 4th ed. São Paulo: Instituto Adolfo Lutz.
36. Association of Official Analytical Chemists (AOAC) (2012) Official Methods of Analysis of the Association of Official Analytical Chemists, 19th ed. Gaithersburg, MD: AOAC International.
37. Association of Official Analytical Chemists (AOAC) (1996) Official method 989.05 fat in milk modified Mojonnier: ether extraction method (first action 1989 and final action 1992). J AOAC Int 71, 898.
38. Molly K, Woestyne MV, De Smet I, et al. (1994) Validation of the Simulator of the Human Intestinal Microbial Ecosystem (SHIME) reactor using microorganism-associated activities. Microbiol Ecol Health Dis 7, 191-200.
39. Possemiers S, Verthé K, Uyttendaele S, et al. (2004) PCR-DGGE-based quantification of stability of the microbial community in a simulator of the human intestinal microbial ecosystem. FEMS Microbiol Ecol 49, 495-507.
40. Duque ALRF, Monteiro M, Adorno MAT, et al. (2016) An exploratory study on the influence of orange juice on gut microbiota using a dynamic colonic model. Food Res Int 84, 160-169.
41. van de Wiele T, Boon N, Possemiers S, et al. (2007) Inulin-type fructans of longer degree of polymerization exert more pronounced in vitro prebiotic effects. J Appl Microbiol 102, 452-460.
42. Bianchi F, Rossi EA, Sakamoto IK, et al. (2014) Beneficial effects of fermented vegetal beverages on human gastrointestinal microbial ecosystem in a simulator. Food Res Int 64, 43-52.
43. Possemiers S, Bolca S, Grootaert C, et al. (2006) The prenylflavonoid isoxanthohumol from hops (Humulus lupulus L.) is activated into the potent phytoestrogen 8-prenylnaringenin in vitro and in the human intestine. J Nutr 136, 1862-1867.
44. Herbel SR, Lauzat B, von Nickisch-Rosenegk M, et al. (2013) Species-specific quantification of probiotic lactobacilli in yoghurt by quantitative real-time PCR. J Appl Microbiol 115, 1402-1410.
45. Junick J & Blaut M (2012) Quantification of human fecal Bifidobacterium species by use of quantitative real-time PCR analysis targeting the groEL gene. Appl Environ Microbiol 78, 2613-2622.
46. Wang Y & Qian PY (2009) Conservative fragments in bacterial 16S rRNA genes and primer design for 16S ribosomal DNA amplicons in metagenomic studies. PLoS ONE 4, e7401.
47. Caporaso JG, Lauber CL, Walters WA, et al. (2011) Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. PNAS 108, 4516-4522.
48. Christoff AP, Sereia AFR, Boberg DR, et al. (2017) Bacterial identification through accurate library preparation and high-throughput sequencing [white paper: Bacterial NGS Sequencing]. Neoprospecta Microbiome Technologies.
49. Edgar RC, Haas BJ, Clemente JC, et al. (2011) UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27, 2194-2200.
50. Caporaso JG, Kuczynski J, Stombaugh J, et al. (2010) QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7, 335-336.
51. Edgar RC (2010) Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26, 2460-2461.
52. McDonald D, Price MN, Goodrich J, et al. (2012) An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J 6, 610-618.
53. Wang Q, Garrity GM, Tiedje JM, et al. (2007) Naïve Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 73, 5261-5267.
54. Caporaso JG, Bittinger K, Bushman FD, et al. (2010) PyNAST: a flexible tool for aligning sequences to a template alignment. Bioinformatics 26, 266-267.
55. Chao A & Bunge J (2002) Estimating the number of species in a stochastic abundance model. Biometrics 58, 531-539.
56. Shannon CE (1948) A mathematical theory of communication. Bell Syst Tech J 27, 379-423.
57. Hamady M, Lozupone C & Knight R (2010) Fast UniFrac: facilitating high-throughput phylogenetic analyses of microbial communities including analysis of pyrosequencing and PhyloChip data. ISME J 4, 17-27.
58. Lozupone C & Knight R (2005) UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol 71, 8228-8235.
59. Agência Nacional de Vigilˆncia Sanitária (ANVISA) (Brazilian Health Regulatory Agency) (2000) Regulamento técnico para fixação de identidade e qualidade de gelados comestíveis, preparados, pós para o preparo e bases para gelados comestíveis (Technical regulation for the identity and quality setting of edible ice cream, prepared, preparation powders and edible ice cream bases).
60. Verbeke KA, Boobis AR, Chiodini A, et al. (2015) Towards microbial fermentation metabolites as markers for health benefits of prebiotics. Nutr Res 28, 42-66.
61. Duysburgh C, Van den Abbeele P, Krishnan K, et al. (2019) A synbiotic concept containing spore-forming Bacillus strains and a prebiotic fiber blend consistently enhanced metabolic activity by modulation of the gut microbiome in vitro. Int J Pharm X 1, 100021.
62. Wang M, Wichienchot S, He X, et al. (2019) In vitro colonic fermentation of dietary fibers: fermentation rate, short-chain fatty acid production and changes in microbiota. Trends Food Sci Technol 88, 1-9.
63. Yang J, Martínez I, Walter J, et al. (2013) In vitro characterization of the impact of selected dietary fibers on fecal microbiota composition and short chain fatty acid production. Anaerobe 23, 74-81.
64. Huda-Faujan N, Abdulamir AS, Fatimah AB, et al. (2010) The impact of the level of the intestinal short chain fatty acids in inflammatory bowel disease patients versus healthy subjects. Open Biochem J 4, 53-58.
65. Böttcher MF, Nordin EK, Sandin A, et al. (2000) Microfloraassociated characteristics in faeces from allergic and nonallergic infants. Clin Exp Allergy 30, 1590-1596.
66. Hijova E & Chmelarova A (2007) Short chain fatty acids and colonic health. Bratisl Lek Listy 108, 354-358.
67. Feng W, Ao H & Peng C (2018) Gut microbiota, short-chain fatty acids, and herbal medicines. Front Pharmacol 9, 1-12.
68. Chaikham P & Rattanasena P (2017) Combined effects of low-fat ice cream supplemented with probiotics on colon microfloral communities and their metabolites during fermentation in a human gut reactor. Food Biosci 17, 35-41.
69. Topping DL & Clifton PM (2001) Short-chain fatty acids and human colonic function: roles of resistant starch and non starch polysaccharides. Physiol Rev 81, 1031-1064.
70. Macfarlane S & Macfarlane GT (2003) Regulation of shortchain fatty acid production. Proc Nutr Soc 62, 67-72.
71. McNeil NI, Cummings JH & James WPT (1978) Short chain fatty acid absorption by the human large intestine. Gut 19, 819-822.
72. Moens F, Van den Abbeele P, Basit AW, et al. (2019) A fourstrain probiotic exerts positive immunomodulatory effects by enhancing colonic butyrate production in vitro. Int J Pharm 555, 1-10.
73. Venegas DP, De la Fuente MK, Landskron G, et al. (2019) Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol 10, 277.
74. Macfarlane GT & Gibson GR (1994) Metabolic activities of the normal colonic flora. In Human Health: The Contribution of Microorganisms, pp. 17-52 [SAW Gibson, editor]. London: Springer.
75. Hu G-X, Chen G-R, Xu H, et al. (2010) Activation of the AMP activated protein kinase by short-chain fatty acids is the main mechanism underlying the beneficial effect of a high fiber diet on the metabolic syndrome. Med Hypotheses 74, 123-126.
76. Blouin J-M, Penot G, Collinet M, et al. (2011) Butyrate elicits a metabolic switch in human colon cancer cells by targeting the pyruvate dehydrogenase complex. Int J Cancer 128, 2591-2601.
77. Macfarlane GT & Macfarlane S (2012) Bacteria, colonic fermentation, and gastrointestinal health. J AOAC Int 95, 50-60.
78. Ríos-Covián D, Ruas-Madiedo P, Margolles A, et al. (2016) Intestinal short chain fatty acids and their link with diet and human health. Front Microbiol 7, 185.
79. Windey K, De Preter V & Verbeke K (2011) Relevance of protein fermentation to gut health. Mol Nutr Food Res 56, 184-196.
80. Allsopp P, Possemiers S, Campbell D, et al. (2013) An exploratory study into the putative prebiotic activity of fructans isolated from Agave angustifolia and the associated anticancer activity. Anaerobe 22, 38-44.
81. Terpend K, Possemiers S, Daguet D, et al. (2013) Arabinogalactan and fructo-oligosaccharides have a different fermentation profile in the Simulator of the Human Intestinal Microbial Ecosystem (SHIME®). Environ Microbiol Rep 5, 595-603.
82. Montalto M, D'Onofrio F, Gallo A, et al. (2009) Intestinal microbiota and its functions. Dig Liver Dis 3, 30-34.
83. Scott KP, Gratz SW, Sheridan PO, et al. (2013) The influence of diet on the gut microbiota. Pharmacol Res 69, 52-60.
84. Andriamihaja M, Davila A-M, Eklou-Lawson M, et al. (2010) Colon luminal content and epithelial cell morphology are markedly modified in rats fed with a high-protein diet. Am J Physiol Gastrointest Liver Physiol 299, G1030-G1037.
85. Dominika S, Arjan N, Karyn RP, et al. (2011) The study on the impact of glycated pea proteins on human intestinal bacteria. Int J Food Microbiol 145, 267-272.
86. Davila A-M, Blachier F, Gotteland M, et al. (2013) Intestinal luminal nitrogen metabolism: role of the gut microbiota and consequences for the host. Pharmacol Res 68, 95-107.
87. Watanabe A, Sakai T, Sato S, et al. (1997) Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy. Hepatology 26, 1410-1414.
88. Sharma BC, Sharma P, Agrawal A, et al. (2009) Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo. Gastroenterology 137, 885-891.
89. Hamer HM, De Preter V, Windey K, et al. (2012) Functional analysis of colonic bacterial metabolism: relevant to health? Am J Physiol Gastrointest Liver Physiol 302, G1-G9.
90. Rochet V, Rigottier-Gois L, Ledaire A, et al. (2008) Survival of Bifidobacterium animalis DN-173 010 in the faecal microbiota after administration in lyophilised form or in fermented product-A randomised study in healthy adults. J Mol Microbiol Biotechnol 14, 128-136.
91. Breban M (2016) Gut microbiota and inflammatory joint diseases. Joint Bone Spine 83, 645-649.
92. Unno T, Choi J-H, Hur H-G, et al. (2015) Changes in human gut microbiota influenced by probiotic fermented milk ingestion. J Dairy Sci 98, 3568-3576.
93. Rettedal EA, Altermann E, Roy NC, et al. (2019) The effects of unfermented and fermented cow and sheep milk on the gut microbiota. Front Microbiol 10, 458.
94. Saarela MH (2019) Safety aspects of next generation probiotics. Curr Opin Food Sci 30, 8-13.
95. Tap J, Mondot S, Levenez F, et al. (2009) Towards the human intestinal microbiota phylogenetic core. Environ Microbiol 11, 2574-2584.
96. Tap J, Derrien M, Törnblom H, et al. (2017) Identification of an intestinal microbiota signature associated with severity of irritable bowel syndrome. Gastroenterology 152, 111-123.
97. Manichanh C, Rigottier-Gois L, Bonnaud E, et al. (2006) Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55, 205-211.
98. Sokol H, Pigneur B, Watterlot L, et al. (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105, 16731-16736.
99. Zhang M, Qiu X, Zhang H, et al. (2014) Faecalibacterium prausnitzii inhibits interleukin-17 to ameliorate colorectal colitis in rats. PLOS ONE 9, e109146.
100. Pittayanon R, Lau JT, Yuan Y, et al. (2019) Gut microbiota in patients with irritable bowel syndrome-A systematic review. Gastroenterology 157, 97-108.
101. Lopez-Siles M, Duncan SH, Garcia-Gil LJ, et al. (2017) Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics. ISME J 11, 841-852.
102. Duncan SH, Hold GL, Harmsen HJM, et al. (2002) Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int J Syst Evol Microbiol 52, 2141-2146.
103. Rivière A, Selak M, Lantin D, et al. (2016) Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut. Front Microbiol 7, 979.
104. Fujimoto T, Imaeda H, Takahashi K, et al. (2013) Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease. J Gastroenterol Hepatol 28, 613-619.
105. Martín R, Miquel S, Chain F, et al. (2015) Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model. BMC Microbiol 15, 67.
106. Zhang X, Shen D, Fang Z, et al. (2013) Human gut microbiota changes reveal the progression of glucose intolerance. PLOS ONE 8, e71108.
107. Bervoets L, Van Hoorenbeeck K, Kortleven I, et al. (2013) Differences in gut microbiota composition between obese and lean children: a cross-sectional study. Gut Pathog 5, 10.
108. Jiang H, Ling Z, Zhang Y, et al. (2015) Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun 48, 186-194.
109. Zhuang Z-Q, Shen L-L, Li W-W, et al. (2018) Gut microbiota is altered in patients with Alzheimer's disease. J Alzheimers Dis 63, 1337-1346.
110. O'Toole PW, Marchesi JR & Hill C (2017) Next-generation probiotics: the spectrum from probiotics to live biotherapeutics. Nat Microbiol 2, 17057.
111. Hsiao EY, McBride SW, Hsien S, et al. (2013) The microbiota modulates gut physiology and behavioral abnormalities associated with autism. Cell 155, 1451-1463.
112. Lee MY, Kim YJ, Gu HJ, et al. (2016) A case of bacteremia caused by Dialister pneumosintes and Slackia exigua in a patient with periapical abscess. Anaerobe 38, 36-38.
113. Tito RY, Cypers H, Joossens M, et al. (2017) Dialister as a microbial marker of disease activity in spondyloarthritis. Arthritis Rheum 69, 114-121.
114. Valles-Colomer M, Falony G, Darzi Y, et al. (2019) The neuroactive potential of the human gut microbiota in quality of life and depression. Nat Microbiol 4, 623-632.
115. Dinan TG, Stanton C & Cryan JF (2013) Psychobiotics: a novel class of psychotropic. Biol Psychiatry 74, 720-726.
116. Takada M, Nishida K, Kataoka-Kato A, et al. (2016) Probiotic Lactobacillus casei strain Shirota relieves stress-associated symptoms by modulating the gut-brain interaction in human and animal models. Neurogastroenterol Motil 28, 1027-1036.
117. Slykerman RF, Hood F, Wickens K, et al. (2017) Effect of Lactobacillus rhamnosus HN001 in pregnancy on postpartum symptoms of depression and anxiety: a randomised double-blind placebo-controlled trial. EBioMedicine 24, 159-165.